These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23081821)

  • 21. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
    Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
    Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
    Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
    Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
    Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
    Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of CD133(+) cells on the radiosensitivity of rectal cancer cells].
    Qiu J; Yang G; Shen Z; Ding L; Wang D; Wang C
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):103-8. PubMed ID: 24796457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD133 in differentiated thyroid cancer of young patients.
    Decaussin-Petrucci M; Deladoëy J; Hafdi-Nejjari Z; Sassolas G; Borson-Chazot F; Abu-Khudir R; Fusco A; Descotes F; Cournoyer S; Sartelet H;
    J Clin Pathol; 2015 Jun; 68(6):434-40. PubMed ID: 25770162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and expansion of human colon-cancer-initiating cells.
    Ricci-Vitiani L; Lombardi DG; Pilozzi E; Biffoni M; Todaro M; Peschle C; De Maria R
    Nature; 2007 Jan; 445(7123):111-5. PubMed ID: 17122771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors.
    Liu Q; Nguyen DH; Dong Q; Shitaku P; Chung K; Liu OY; Tso JL; Liu JY; Konkankit V; Cloughesy TF; Mischel PS; Lane TF; Liau LM; Nelson SF; Tso CL
    J Neurooncol; 2009 Aug; 94(1):1-19. PubMed ID: 19468690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation and identification of CD133 positive and negative cells from human lung cancer and screening of the differential genes between the positive and negative cells].
    Zheng S; Li S; Wang H; Xie X; Zhang Y
    Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):123-30. PubMed ID: 25800567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
    Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
    Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
    Huang X; Sheng Y; Guan M
    Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.
    Chen KH; Hsu CC; Song WS; Huang CS; Tsai CC; Kuo CD; Hsu HS; Tsai TH; Tsai CY; Woung LC; Chiou SH; Lu KH; Chen YW
    Childs Nerv Syst; 2010 Nov; 26(11):1605-12. PubMed ID: 20526717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
    Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
    FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116.
    Dittfeld C; Dietrich A; Peickert S; Hering S; Baumann M; Grade M; Ried T; Kunz-Schughart LA
    Radiother Oncol; 2009 Sep; 92(3):353-61. PubMed ID: 19699546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy.
    Kubo T; Takigawa N; Osawa M; Harada D; Ninomiya T; Ochi N; Ichihara E; Yamane H; Tanimoto M; Kiura K
    Cancer Sci; 2013 Jan; 104(1):78-84. PubMed ID: 23066953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.